Attorney General Mayes Reports Life-Saving Impact of Naloxone Distribution Program
More than 500 Overdose Reversals Reported as a Result of Naloxone Distribution
PHOENIX — Attorney General Kris Mayes today announced significant milestones in her office’s statewide naloxone distribution program, funded through opioid settlement agreements with major pharmaceutical distributors and manufacturers. The Attorney General's Office reports that more than at least 500 lives have been saved to date based on reporting from the organizations receiving naloxone.
"Every unit of naloxone we put into the hands of a first responder, a shelter worker, a healthcare provider, a teacher or a parent is a chance at saving a life,” said Attorney General Mayes. “At least 500 Arizonans are alive today because we held pharmaceutical companies accountable and used their settlement dollars to fund real, life-saving solutions. My office will continue providing naloxone to every community in need of this life saving treatment."
In 2024 and 2025, Teva Pharmaceuticals shipped 55,442 units (110,884 doses) of naloxone — each containing two doses — to thirteen Arizona counties and eight community-based organizations, including Andre House, Central Arizona Shelter Services (CASS), Sonoran Prevention Works, Arizona Poison Control, and the Arizona High Intensity Drug Trafficking Area (AZ HIDTA). These recipients further distributed the drug to 24 additional community organizations, 35 schools, 63 healthcare agencies and physicians, members of the public, and the Hopi Nation.
In 2026, the program has continued:
- Teva will ship a total of 27,721 units this year
- Hikma Pharmaceuticals will ship 6,599 units, anticipated by year's end
- Amneal Pharmaceuticals will begin a four-year commitment with its first shipment of 8,428 units, ordered in September 2026
Community organizations report reversing as many as 12 overdoses per day using naloxone obtained through these programs. The ADHS Opioid Dashboard tracks statewide overdose data from 2017 to present.